Choong Ang Vaccine Laboratory Co., Ltd. (KOSDAQ:072020)

South Korea flag South Korea · Delayed Price · Currency is KRW
9,880.00
-140.00 (-1.40%)
Last updated: Jun 13, 2025
-11.63%
Market Cap 92.75B
Revenue (ttm) 39.19B
Net Income (ttm) 3.65B
Shares Out 9.31M
EPS (ttm) 375.11
PE Ratio 26.55
Forward PE n/a
Dividend 170.00 (1.71%)
Ex-Dividend Date Dec 27, 2024
Volume 23,875
Average Volume 22,133
Open 10,020.00
Previous Close 10,020.00
Day's Range 9,870.00 - 10,050.00
52-Week Range 9,000.00 - 11,480.00
Beta 0.52
RSI 52.66
Earnings Date Aug 26, 2025

About KOSDAQ:072020

Choong Ang Vaccine Laboratory Co., Ltd., operates as an animal vaccine company, primarily engages in the production and sale of pharmaceutical products that promote animal health and welfare in Korea. Its vaccine products include SuiShot, PoulShot, CaniShot, BoviShot, FeliShot, RabbiShot, and AquaShot for preventing diseases and infection in pigs, poultry, dogs, cattle, cats, rabbits, and fish. The company was founded in 1968 and is based in Daejeon, South Korea. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 1968
Employees 167
Stock Exchange KOSDAQ
Ticker Symbol 072020
Full Company Profile

Financial Performance

In 2022, KOSDAQ:072020's revenue was 39.30 billion, a decrease of -3.95% compared to the previous year's 40.91 billion. Earnings were 4.04 billion, a decrease of -46.80%.

Financial Statements

News

There is no news available yet.